Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025)
Historic Assets Average for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $9.9 million.
- Cyclerion Therapeutics' Assets Average rose 433.48% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 433.48%. This contributed to the annual value of $11.5 million for FY2024, which is 2703.72% down from last year.
- As of Q3 2025, Cyclerion Therapeutics' Assets Average stood at $9.9 million, which was up 433.48% from $9.6 million recorded in Q2 2025.
- Cyclerion Therapeutics' 5-year Assets Average high stood at $107.7 million for Q1 2021, and its period low was $9.2 million during Q4 2024.
- Moreover, its 5-year median value for Assets Average was $14.3 million (2023), whereas its average is $31.6 million.
- Per our database at Business Quant, Cyclerion Therapeutics' Assets Average tumbled by 7363.16% in 2023 and then surged by 433.48% in 2025.
- Quarter analysis of 5 years shows Cyclerion Therapeutics' Assets Average stood at $63.5 million in 2021, then tumbled by 66.06% to $21.6 million in 2022, then tumbled by 33.72% to $14.3 million in 2023, then plummeted by 35.38% to $9.2 million in 2024, then rose by 7.1% to $9.9 million in 2025.
- Its Assets Average stands at $9.9 million for Q3 2025, versus $9.6 million for Q2 2025 and $9.7 million for Q1 2025.